Cargando…
Recent Advances in Cancer Drug Discovery Through the Use of Phenotypic Reporter Systems, Connectivity Mapping, and Pooled CRISPR Screening
Multi-omic approaches offer an unprecedented overview of the development, plasticity, and resistance of cancer. However, the translation from anti-cancer compounds identified in vitro to clinically active drugs have a notoriously low success rate. Here, we review how technical advances in cell cultu...
Autores principales: | Salame, Natasha, Fooks, Katharine, El-Hachem, Nehme, Bikorimana, Jean-Pierre, Mercier, François E., Rafei, Moutih |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250974/ https://www.ncbi.nlm.nih.gov/pubmed/35795568 http://dx.doi.org/10.3389/fphar.2022.852143 |
Ejemplares similares
-
Humoral Immunity to Allogeneic Immunoproteasome-Expressing Mesenchymal Stromal Cells Requires Efferocytosis by Endogenous Phagocytes
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
Thymoproteasome-Expressing Mesenchymal Stromal Cells Confer Protective Anti-Tumor Immunity via Cross-Priming of Endogenous Dendritic Cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2021) -
UM171A-induced ROS promote antigen cross-presentation of immunogenic peptides by bone marrow-derived mesenchymal stromal cells
por: Salame, Natasha, et al.
Publicado: (2022) -
The CIt protocol: A blueprint to potentiate the immunogenicity of immunoproteasome-reprogrammed mesenchymal stromal cells
por: Bikorimana, Jean-Pierre, et al.
Publicado: (2022) -
LSD1 Inhibition Enhances the Immunogenicity of Mesenchymal Stromal Cells by Eliciting a dsRNA Stress Response
por: Mardani, Fatemeh, et al.
Publicado: (2022)